MK.|&||J4G{(Z>X(]1~7IW(]:GY3JS$$M-9+#(C3?A==ZVU
SYSTEM PROCESSING...
MK.|&||J4G{(Z>X(]1~7IW(]:GY3JS$$M-9+#(C3?A==ZVU
SYSTEM PROCESSING...
Posted: 2025-04-29 13:48:34 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-29 13:48:57 UTC
Verified By
Rollup News
Merck is investing $1 billion to build a new factory in Delaware for producing its cancer drug Keytruda, aiming to avoid tariffs and prepare for patent expirations by developing an easier-to-use version of the drug.
Merck's $1 billion investment in a new Delaware factory.
Production of Keytruda, a cancer drug with $29.5 billion in sales last year.
Avoiding tariffs by manufacturing in the U.S.
Development of a new, easier-to-use version of Keytruda.
Preparing for patent expirations in 2028.
Upcoming tariffs on overseas manufacturing.
Patent expiration of Keytruda in 2028.